Intravenous thrombolysis in stroke patients under 55 years of age: Is there a different effect according to etiology and severity?

Journal of Thrombosis and Thrombolysis

Volumn 37, Issue 4, 2014, Pages 557-564

  Prefasi, Daniel ^a   Fuentes, Blanca ^a   Martínez Sánchez, Patricia ^a   Rodríguez Sanz, Ana ^a   Ruiz Ares, Gerardo ^a   Sanz Cuesta, Borja ^a   Lara, Manuel Lara ^a   Díez Tejedor, Exuperio ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Cardioembolism; Intravenous thrombolysis; Ischemic stroke; Stroke etiology; Stroke severity; Young patients

Indexed keywords

ADULT; ARTERY DISSECTION; ARTICLE; BRAIN ISCHEMIA; CARDIOEMBOLIC STROKE; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROGNOSIS; RANKIN SCALE; THROMBOSIS; AGE; CLINICAL TRIAL; DISEASE FREE SURVIVAL; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; MORTALITY; PATHOLOGY; RETROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; STROKE; SURVIVAL RATE; TIME;

ADULT; AGE FACTORS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STROKE; SURVIVAL RATE; THROMBOLYTIC THERAPY; TIME FACTORS;

EID: 84899926083     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-013-0984-y     Document Type: Article

References (34)

1. Putaala J, Metso AJ, Metso TM et al (2009) Analysis of 1008 consecutive patients aged 15 to 49 with first-ever ischemic stroke: the Helsinki young stroke registry. Stroke 40:1195-1203
2. Díaz-Guzmán J, Egido JA, Gabriel-Sánchez R, Barberá-Comes G, Fuentes-Gimeno B, Fernández-Pérez C, IBERICTUS Study Investigators of the Stroke Project of the Spanish Cerebrovascular Diseases Study Group (2012) Stroke and transient ischemic attack incidence rate in Spain: the IBERICTUS study. Cerebrovascular Dis 34:272-281
3. Kissela BM, Khoury JC, Alwell K et al (2012) Age at stroke: temporal trends in stroke incidence in large, biracial population. Neurology 79:1781-1787
4. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group (1995) Tissue Plasminogen activator for acute ischemic stroke. N Engl J Med 333:1581-1587
5. Hacke W, Kaste M, Bluhmki E et al (2008) Thrombolysis with alteplase 3 to 4.5 h after acute ischemic stroke. N Engl J Med 359:1317-1329
6. Lees KR, Bluhmki E, von Kummer R, ECASS, ATLANTIS, NINDS and EPITHET rt-PA Study Group et al (2010) Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 15:1695-1703
7. Galldiks N, Zaro-Weber O, Dohmen C et al (2010) Systemic thrombolysis with rt-PA in patients under 40 years of age: a subgroup analysis of the cologne stroke experience. Cerebrovasc Dis 30:514-518
8. Putaala J, Metso TM, Metso AJ et al (2009) Thrombolysis in young adults with ischemic stroke. Stroke 40:2085-2091
9. Toni D, Ahmed N, Anzini A, SITS investigators et al (2012) Intravenous thrombolysis in young stroke patients: results from the SITS-ISTR. Neurology 78:880-887
10. Ji R, Schwamm LH, Pervez MA, Singhal AB (2013) Ischemic stroke and transient ischemic attack in young adults risk factors, diagnostic yield, neuroimaging, and thrombolysis. JAMA Neurol 70:51-57
11. Wagner JC, Lutsep HL (2005) Thrombolysis in young adults. J Thromb Thrombolysis 20:133-136 (Pubitemid 41554446)
12. Poppe AY, Buchan AM, Hill MD (2009) Intravenous thrombolysis for acute ischaemic stroke in young adult patients. Can J Neurol Sci 36:161-167
13. Ferro JM, Massaro AR, Mas JL (2010) Aetiological diagnosis of ischaemic stroke in young adults. Lancet Neurol 9:1085-1096
14. Kristensen B, Malm J, Carlberg B et al (1997) Epidemiology and etiology of ischemic stroke in young adults aged 18 to 44 years in Northern Sweden. Stroke 28:1702-1709 (Pubitemid 27391436)
15. Mustanoja S, Maretoja A, Putaala J et al (2011) Outcome by stroke etiology in patients receiving thrombolytic treatment: descriptive subtype analysis. Stroke 42:102-106
16. Fluri F, Hatz F, Rutgers MP et al (2010) Intravenous thrombolysis in patients with stroke attributable to small artery occlusion. Eur J Neurol 17:1054-1060
17. Shobha N, Fang J, Hill MD. Do lacunar strokes benefit from thrombolysis? Evidence from the Registry of the Canadian Stroke Network. Int J Stroke. Published online first 11 December 2012. doi: 10.1111/j.1747-4949.2012.00932.x
18. Cocho D, Belvís R, Martí-Fàbregas J et al (2006) Does thrombolysis benefit patients with lacunar syndrome? Eur Neurol 55:70-73 (Pubitemid 43760316)
19. Engelter ST, Rutgers MP, Hatz F et al (2009) Intravenous thrombolysis in stroke attributable to cervical artery dissection. Stroke 40:3772-3776
20. Fuentes B, Masjuan J, de Alonso LM et al (2012) Benefits of intravenous thrombolysis in acute ischemic stroke related to extracraneal internal carotid dissection: dream or reality? Int J Stroke 7:7-13
21. Zinkstok SM, Vergouwen MDI, Engelter ST et al (2011) Safety and functional outcome of thrombolysis in dissection-related ischemic stroke: a meta-analysis of individual patient data. Stroke 42:2515-2520
22. Budimkić MS, Berisavac I, Beslać-Bumbaširević L et al (2012) Intravenous thrombolysis in the treatment of ischemic stroke due to spontaneous artery dissection. Neurologist 18:273-276
23. Molina CA, Montaner J, Arenillas JF, Ribo M, Rubiera M, Alvarez-Sabín J (2004) Differential pattern of tissue plasminogen activator-induced proximal middle cerebral artery recanalization among stroke subtypes. Stroke 35:486-490 (Pubitemid 38174434)
24. Rocha S, Pires A, Gomes J et al (2011) Intravenous thrombolysis is more effective in ischemic cardioembolic strokes than in noncardioembolic? Arq Neuropsiquiatr 69:905-909
25. Fuentes B, Martínez-Sánchez P, De Alonso LM et al (2012) Efficacy of intravenous thrombolysis according to stroke subtypes: the Madrid Stroke Network data. Eur J Neurol 19:1568-1574
26. Hsia AW, Sachdev HS, Tomlinson J, Hamilton SA, Tong DC (2003) Efficacy of IV tissue plasminogen activator in acute stroke: does stroke subtype really matter? Neurology 61:71-75 (Pubitemid 36818749)
27. Huisa BN, Raman R, Neil W, Ernstrom K, Hemmen TM (2012) Intravenous tissue plasminogen activator for patients with minor ischemic stroke. J Stroke Cerebrovasc Dis 21:732-736
28. Mishra NK, Lyden P, Grotta JC, Lees KR, VISTA Collaborators (2010) Thrombolysis is associated with consistent improvement across baseline stroke severity. A comparison of outcome in patients from the Virtual International Stroke Trials Archive (VISTA). Stroke 41:2612-2617
29. Fuentes B, Díez-Tejedor E, Ortega-Casarrubios MA, Martínez P, Lara M, Frank A (2006) Consistency of the benefits of stroke units over years of operation: an 8-year effectiveness analysis. Cerebrovasc Dis 21:173-179
30. Bogousslavsky J, van Melle G, Regli F (1988) The lausanne stroke registry: analysis of 1000 consecutive patients with first stroke. Stroke 19:1083-1092
31. Arboix A, Alvarez-Sabín J, Soler L (1998) Stroke classification and diagnostic criteria. Ad hoc Editorial Committee of the Task Force on Cerebrovascular Diseases of SEN. Neurología 13:3-10
32. Stroke Therapy Academic Industry Roundtable II (2001) Recommendations for clinical trial evaluation of acute stroke therapies. Stroke 32:1598-1606
33. Martínez-Martínez M, Cazorla-García R, Rodríguez Antonio LA, Martínez-Sánchez P, Fuentes B, Diez-Tejedor E (2010) Hipercoagulability and ischemic stroke in young patients. Neurología 25:343-348
34. Martínez-Sánchez P, Martínez-Martínez M, Fuentes B et al (2011) Migraine and hypercoagulable states in ischemic stroke. Cephalalgia 31:1609-1617